Funny you should compare Vascepa's launch to Elqiquis's—that's exactly what JZ did on today's CC!
Regardless of how you spin it, the slow launch makes it somewhat less likely that Vascepa sales will ultimately reach the lofty targets that some have projected.
Market Data 
Markets 
AI
